Washington, Nov 5 (AFP/APP):Pfizer said Friday that a clinical trial of its first-of-its-kind pill to treat Covid-19 shows it is highly effective.
The drug called Paxlovid achieved an 89 percent reduction in risk of hospitalization or death among adult patients with Covid who are at high risk of progressing to severe illness, Pfizer said.